NCT03297931Completed
Comparison of Pulse Chips and Commercial Snacks on Food Intake, Appetite and Blood Glucose in Healthy Young Adults
Comparison of Roasted Pulse Snacks, Pulse Chips and Commercial Snacks on Post-prandial Food Intake, Appetite and Glycemic Response in Healthy Young Adults
Source: ClinicalTrials.gov · Last updated 28 Mar 2025
Brief summary (registry, in English)
Consumers are often forced to eat fast, convenient foods and snacks ("eat on the go") in order to match the pace of their lifestyles. However, these snack options more often than not offer little health benefit to the consumer. In fact, 55% of calories consumed by Canadians are ultra processed foods, which are limited in their nutrient profile and only offer empty calories. Subsequently, these foods lead the consumer to eat more and provides little to no feelings of satiety or satiation. the proposed objectives of the current project are to examine the physiological benefit(s) of consuming readily available pulse snacks and compare them to other commonly consumed snack varieties. This work aims to incentivize consumers to seek out pulses as valuable snacking options and highlight the benefit of including these as alternatives to other energy-dense snacks that lack the nutritional composition of pulses.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 25 Sept 2017
- Start date
- 19 Jul 2017
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- University of Toronto
- Diseases
- Obesity
- NCT number
- NCT03297931
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 19 Jul 2017 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of cardiovascular disease, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorptive syndrome, pancreatitis, gallbladder or biliary disease.
- Patients who have undergone bariatric surgery at any point.
- Weight gain or loss of at least 10 lbs in previous three months.
Other illness
- Presence of gastrointestinal disorder or surgeries within the past year.
- Known intolerance, sensitivity or allergy to pulses or dairy.
- Uncontrolled hypertension (systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg) as defined by the average blood pressure measured at screening.
Lab values
- Fasting blood glucose \> 5.6 mmol/L
- Consuming prescription or non-prescription drug, herbal or nutritional supplements known to affect blood glucose or that could affect the outcome of the study as per investigator's judgement.
Other
- Smoking
- Thyroid problems
- Known to be pregnant or lactating.
- Unwillingness or inability to comply with the experimental procedures
- Extreme dietary habits (ie. Atkins diet, very high protein diets, etc.).
- Excessive alcohol intake (more than 2 drinks per day or more than 9 drinks per week)
- Restrained Eaters
Who the study is looking for
- Age: ≥18 and ≤45 years
- BMI: ≥ 18.5 and ≤ 29.9 kg/m2
- Fasting serum glucose: ≤ 5.6 mmol/L
- Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
- Willing to maintain current dietary supplement use throughout the trial. On test days, subject agrees not to take any dietary supplements until dismissal from the Department of Nutritional Sciences. Failure to comply will result in a rescheduled test visit.
- Willing to abstain from alcohol consumption for 24 h prior to all test visits.
- Willing to avoid vigorous physical activity for 24 h prior to all test visits.
- Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.
Age in the registry: 18 years to 45 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Toronto Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.